Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Tim_Lu
|
| gptkbp:developedBy |
gene circuits
programmable cell therapies |
| gptkbp:focusesOn |
synthetic biology
gene therapy |
| gptkbp:foundedYear |
2016
|
| gptkbp:founder |
gptkb:Wilson_Wong
gptkb:Jim_Collins gptkb:Philip_Lee gptkb:Tim_Lu |
| gptkbp:headquartersLocation |
gptkb:South_San_Francisco,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Senti Biosciences
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:mission |
engineer next-generation cell and gene therapies using synthetic biology
|
| gptkbp:notableProduct |
gptkb:SENTI-202
gptkb:SENTI-301 gptkb:SENTI-401 |
| gptkbp:publiclyTraded |
yes
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:SNTI
|
| gptkbp:website |
https://www.sentibio.com/
|
| gptkbp:bfsParent |
gptkb:Senti_BioLogic_platform
gptkb:Tim_Lu gptkb:South_San_Francisco,_California,_USA gptkb:Timothy_Lu |
| gptkbp:bfsLayer |
7
|